Collaboration between Personalis and Tempus established, with Tempus serving as Personalis’ exclusive commercial partner and expanding to include colorectal cancer.
1 report, 1 independent
Updated Jul 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Collaboration between Personalis and Tempus established, with Tempus serving as Personalis’ exclusive commercial partner and expanding to include colorectal cancer.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Eric Lefkofsky is CEO of Tempus, and the company utilizes Personalis technology which has successfully secured Medicare coverage.Sub-event
Personalis and Tempus partnered, with Tempus becoming the exclusive commercial partner and adding colorectal cancer focus.1 source
Keep exploring
The entities involved
-
Personalis (United States)
company in Menlo Park, United States
Nothing else this week.
-
Tempus
biotechnology company based in Chicago, Illinois
Coverage
Newest first; wire copies grouped- Business WirePersonalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients Collaboration extension through 2029 accelerates access to MRD techn